Patents by Inventor Masakuni Horiguchi

Masakuni Horiguchi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10869858
    Abstract: It is an object of the present invention to provide a novel therapeutic agent and method for treating amyotrophic diseases, and more specifically a therapeutic agent and method for treating neurogenic amyotrophic disorders such as amyotrophic lateral sclerosis (ALS) and myogenic amyotrophic disorders such as sarcopenia or disuse muscle atrophy. Provided is a therapeutic agent for amyotrophic diseases that comprises one or more compounds selected from the group consisting of compounds represented by the formula (I), the formula (II) and the formula (III), and pharmaceutically acceptable salts of the compounds when R3 represents OH.
    Type: Grant
    Filed: June 24, 2016
    Date of Patent: December 22, 2020
    Assignee: Tohoku University
    Inventors: Takaaki Abe, Masakuni Horiguchi, Yuji Matsumoto, Maiko Nagayasu, Keiichi Murakami
  • Publication number: 20190054066
    Abstract: It is an object of the present invention to provide a novel therapeutic agent and method for treating amyotrophic diseases, and more specifically a therapeutic agent and method for treating neurogenic amyotrophic disorders such as amyotrophic lateral sclerosis (ALS) and myogenic amyotrophic disorders such as sarcopenia or disuse muscle atrophy. Provided is a therapeutic agent for amyotrophic diseases that comprises one or more compounds selected from the group consisting of compounds represented by the formula (I), the formula (II) and the formula (III), and pharmaceutically acceptable salts of the compounds when R3 represents OH.
    Type: Application
    Filed: June 24, 2016
    Publication date: February 21, 2019
    Inventors: Takaaki ABE, Masakuni HORIGUCHI, Yuji MATSUMOTO, Maiko NAGAYASU, Keiichi MURAKAMI
  • Patent number: 8735397
    Abstract: The invention relates to a method for treating schizophrenia and/or related diseases comprising administering lurasidone and a mGluR2 ligand to a mammal in need thereof.
    Type: Grant
    Filed: March 28, 2011
    Date of Patent: May 27, 2014
    Assignees: Vanderbilt University, Dainippon Sumitomo Pharma Co., Ltd.
    Inventors: Herbert Y. Meltzer, Masakuni Horiguchi
  • Publication number: 20110237602
    Abstract: The invention relates to a method for treating schizophrenia and/or related diseases comprising administering lurasidone and a mGluR2 ligand to a mammal in need thereof.
    Type: Application
    Filed: March 28, 2011
    Publication date: September 29, 2011
    Applicants: Vanderbilt University, Dainippon Sumitomo Pharma Co., Ltd.
    Inventors: Herbert Y. MELTZER, Masakuni Horiguchi